SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000850261-20-000011
Filing Date
2020-01-17
Accepted
2020-01-17 16:17:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A srnes-3ano3.htm S-3/A 373671
2 EX-23.1 consents-3amendmentno3.htm EX-23.1 3111
3 GRAPHIC image1.jpg GRAPHIC 14546
4 GRAPHIC image11.jpg GRAPHIC 13004
5 GRAPHIC image2.jpg GRAPHIC 13004
6 filename6.htm CORRESP 14184
  Complete submission text file 0000850261-20-000011.txt   448352
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-234869 | Film No.: 20533779
SIC: 2836 Biological Products, (No Diagnostic Substances)